about
A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysisTransmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting.Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008-2014.National Bloodstream Infection Surveillance in Switzerland 2008-2014: Different Patterns and Trends for University and Community Hospitals.Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014.Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014.Improvement of antibiotic prescription in outpatient care: a cluster-randomized intervention study using a sentinel surveillance network of physicians.Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.Temporal trends of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in in- and outpatients in Switzerland, 2004 to 2011.[Severe hepatocellular damage after administration of paracetamol and chlorzoxazone in therapeutic dosage].Acute severe anaemia in an elderly patient with hereditary sphaerocytosis.Liver failure after long-term nucleoside antiretroviral therapy.Endocarditis after urinary tract infection.African immigrant with weight loss and disseminated skin lesions.Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests.Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.Multifocal vasculopathy due to Varicella-Zoster Virus (VZV): serial analysis of VZV DNA and intrathecal synthesis of VZV antibody in cerebrospinal fluid.Polyclonal proliferation of large granular lymphocytes during cytomegalovirus primary infection in a human immunodeficiency virus-infected patient receiving antiretroviral therapy.Ten years of MRSA surveillance in Switzerland: similarities and differences with Europe.Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting.Burkholderia stabilis outbreak associated with contaminated commercially-available washing gloves, Switzerland, May 2015 to August 2016.Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience.Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland.Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe[Tick-borne illnesses - borreliosis and European tick-borne encephalitis]Different Epidemiology of Hospital-Acquired Bloodstream Infections Between Small Community Hospitals and Large Community HospitalsActive surveillance of antibiotic resistance patterns in urinary tract infections in primary care in SwitzerlandIntra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae: a retrospective observational studyAntimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009-2016)Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trialAntibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic reviewAttributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland
P50
Q34065997-E42EA421-C399-4A0C-8E9A-2AD88E21BCB6Q34719355-86E45927-CA5E-46FE-A2B1-484CF5E75C9FQ35689290-E4118361-8867-47FA-BE20-0CC7B767FC5CQ36218305-417E4ABB-D443-433E-B8D8-5609812A9714Q36757551-347B9A02-A597-46B5-8B34-E147EC20908FQ37728419-8633F39F-D7A3-4169-A697-E1CD5AA36471Q39650523-6ED88F3C-CB76-4C4D-B6C8-9BA1D398D593Q39715205-AC7E07C7-5C22-4567-B3E3-86437810DB00Q40539373-70E53C59-9293-438E-A358-27BD6C05D595Q41696938-ADA45706-9527-4F17-9B3B-0D28C79244BBQ42259330-36E864CE-24DE-4181-A6EA-50C88F1ACB95Q42260735-B6B1B0E6-8405-440B-BE91-2AE0CAD71D11Q42538046-B9BB4DCD-4BC3-416B-A944-BD836B3E2ED2Q43064353-BE77A45C-7972-4307-9CF4-3EC7C8187DCBQ43736873-1B44B2CD-E939-4D30-B6A3-9D0BBE98B057Q44140050-8B7E457D-4AFD-48C2-90FE-028FC28F7CE9Q44449489-77E6E1E2-019D-4E37-90B8-059F61B6A4FDQ44742478-C1C58CE2-3194-4006-9E2C-44BA2AA257B7Q45421088-830C77B9-77B9-48E2-B01F-88A6FB581D28Q45731788-86BAA939-1B52-4C12-B15D-B3EF0FBB5D23Q45736220-6462539A-0D84-4F01-9CD9-0B5FBD85A144Q46036579-EA57F744-0166-4208-89AB-43175DCE0B53Q46553364-6A1106B3-CA5D-459B-BC87-81D150A236A8Q47169001-A733711B-20B1-4119-8103-556985E6FC8BQ47362037-8C2F0A5C-C43A-41FD-B8F4-2F342D21A20DQ47765902-51C0F0DC-234F-4E14-949D-C1EDDD2109FDQ52333196-70E743FC-8E7B-44A4-AF2C-6CD5B19EF168Q56889467-D4D0050D-A283-4926-B6E9-19543ACDFAE9Q84703402-7C3BA34B-C92A-40EA-B6B8-08ACFC08C231Q85644590-54D7DBCE-88FE-469E-928F-32C79631046DQ87716261-F8CD6194-98D7-4CC2-B7AD-6DDD18DD1020Q90600847-734953FD-A79B-48AC-B3BD-96301E14CA0BQ90701266-FBB1F9D5-1711-47D4-B9D4-D6C01C88E159Q92147366-6BEBF88B-0049-4457-9FAA-D80AEF0DA703Q92457554-18BC5E32-4EDD-43AC-A9A9-56912CED4F94Q92989598-25CF4A5C-F2A2-42EC-93FE-C3B7A35B7327Q93199975-010E2851-9ECA-41FA-88F9-AD0239672D0A
P50
description
researcher at the Institute for Infectious Diseases
@en
wetenschapper
@nl
name
Andreas Kronenberg
@ast
Andreas Kronenberg
@en
Andreas Kronenberg
@es
Andreas Kronenberg
@nl
Andreas Kronenberg
@sv
type
label
Andreas Kronenberg
@ast
Andreas Kronenberg
@en
Andreas Kronenberg
@es
Andreas Kronenberg
@nl
Andreas Kronenberg
@sv
prefLabel
Andreas Kronenberg
@ast
Andreas Kronenberg
@en
Andreas Kronenberg
@es
Andreas Kronenberg
@nl
Andreas Kronenberg
@sv
P106
P21
P31
P496
0000-0002-0006-7833